en

PRODUCT DETAIL

Ezetimib/simvastatín Teva B.V. 10 mg/20 mg

Code 1622C
MA number 31/0475/16-S
Product Form: tbl 30x10 mg/20 mg (blis.PVC/Aclar/Al)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Mutual recognition procedure
Therapeutic Class: 31 - HYPOLIPIDAEMICA
ATC:
C CARDIOVASCULAR SYSTEM
C10 Lipid modifying agents
C10B Lipid modifying agents, combinations
C10BA Combinations of various lipid modifying agents
C10BA02 Simvastatin and ezetimibe
Shelf life: 18
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 14.11.2016
Pediatric posology: Yes
Pediatric warnings: Yes
PIL: PIL_Ezetimib-simvastatín Teva B.V._05.2023.pdf  
SPC: SPC_Ezetimib-simvastatín Teva B.V._05.2023.pdf  
Safety feature Yes
Data update: 23.09.2019
eu-flag.png sk-flag.png